GENEVA—Alcon (SIX/NYSE:ALC) said this week that its second-quarter sales increased 5 percent on a reported basis to $2.2 billion, and noted that the increase was 10 percent on a constant currency basis. Sales in both surgical and vision care in the second quarter ended June 30 benefited from “product innovation, continued recovery across international markets from the COVID-19 pandemic and sales from acquired products,” the company’s announcement noted. Operating income in the second quarter totaled $200 million, with an operating margin of 9.1 percent. Read More